| Name | 5-Fluoro-2-iodo-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3-b]pyr idine |
|---|---|
| Synonyms |
5-fluoro-2-iodo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine
5-FLUORO-2-HYDROXYMETHYLPHENYLBORONIC ACID 5-fluoro-2-hydroxy-N-(1(2)H-tetrazol-5-yl)-benzamide |
| Molecular Formula | C14H10FIN2O2S |
|---|---|
| Molecular Weight | 416.20900 |
| Exact Mass | 415.94900 |
| PSA | 60.34000 |
| LogP | 4.40620 |
|
~%
866318-98-1 |
| Literature: Aventis Pharma S.A. Patent: US2007/93480 A1, 2007 ; Location in patent: Page/Page column 44 ; |
|
~%
866318-98-1 |
| Literature: Nemecek, Conception; Metz, William A.; Wentzler, Sylvie; Ding, Fa-Xiang; Venot, Corinne; Souaille, Catherine; Dagallier, Anne; Maignan, Sebastien; Guilloteau, Jean-Pierre; Bernard, Francois; Henry, Alain; Grapinet, Sandrine; Lesuisse, Dominique Chemical Biology and Drug Design, 2010 , vol. 76, # 2 p. 100 - 106 |
|
~%
866318-98-1 |
| Literature: Nemecek, Conception; Metz, William A.; Wentzler, Sylvie; Ding, Fa-Xiang; Venot, Corinne; Souaille, Catherine; Dagallier, Anne; Maignan, Sebastien; Guilloteau, Jean-Pierre; Bernard, Francois; Henry, Alain; Grapinet, Sandrine; Lesuisse, Dominique Chemical Biology and Drug Design, 2010 , vol. 76, # 2 p. 100 - 106 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |